Abstract: Provided is a sulfonyl-substituted bicyclic compound (A) which acts as a ROR? inhibitor, said compound has good ROR? inhibitory activity and is expected to be used for treating diseases mediated by a ROR? receptor in mammals.
Type:
Grant
Filed:
September 30, 2018
Date of Patent:
July 26, 2022
Assignees:
Chia Tai Tianqing Pharmaceutical Group Co., Ltd., Nanjing Gear Pharma & Tech Co., Ltd.
Abstract: Provided is a sulfonyl-substituted bicyclic compound (A) which acts as a ROR? inhibitor, said compound has good ROR? inhibitory activity and is expected to be used for treating diseases mediated by a ROR? receptor in mammals.
Type:
Application
Filed:
September 30, 2018
Publication date:
July 30, 2020
Applicants:
CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD., NANJING GEAR PHARMA & TECH CO., LTD.